Overview
Leishmaniasis was first demonstrated by Sir William Leishman and Charles Donovan in patients from Calcutta in 1903, and the genus was named Leishmania donovani in their honour by Sir Ronald Ross. It remains endemic across South and South-East Asia, China, Sudan, tropical Africa and South America, with Bengal, Bihar and Eastern Uttar Pradesh being major foci in India.
Different Leishmania species cause strikingly different clinical pictures — from the potentially fatal visceral disease kala azar, to the disfiguring cutaneous oriental sore, to the destructive mucocutaneous espundia — making species-specific recognition essential for both prognosis and management.
Learning Objectives
After this lesson you will be able to…- Describe the morphology of the amastigote and promastigote forms of Leishmania
- Explain the life cycle of Leishmania involving the sand fly vector
- Discuss the pathogenicity of visceral, cutaneous and mucocutaneous leishmaniasis
- Explain the laboratory diagnosis of leishmaniasis including microscopy, culture and serology
- Recognise diagnostic challenges of leishmaniasis in immunocompromised patients
Clinical Story
Why This MattersA 10-year-old child from Bihar presents with prolonged intermittent fever, marked hepatosplenomegaly, anaemia and progressive weight loss over several months. A splenic aspirate smear stained with Leishman stain reveals small, oval amastigote (LD) bodies within macrophages — confirming a diagnosis of kala azar (visceral leishmaniasis).
Core Concepts
The amastigote form (2–4 µm, non-motile, round-to-oval) is seen in human tissues (reticuloendothelial cells of liver, spleen, bone marrow, peripheral blood), with a red nucleus and bright red kinetoplast on Leishman stain, plus a blepharoplast, axoneme and vacuole. The promastigote form (15–20 × 1–2 µm, spindle-shaped, with a free anterior flagellum) is seen in the sand fly gut and in artificial culture.
Transmission occurs via the bite of an infected female sand fly (Phlebotomus, Lutzomiya), or rarely via blood transfusion. After a blood meal, amastigotes convert to flagellate promastigotes in the sand fly gut over 8–20 days. When the sand fly bites again, promastigotes are deposited at the bite site, penetrate host macrophages, convert to amastigotes, multiply, and rupture the macrophage to infect new cells. Incubation period is usually 3–6 months but may extend to 1–2 years.
Leishmania donovani causes kala azar (visceral leishmaniasis): hepatosplenomegaly, intermittent fever, anaemia, cachexia, dry skin, brittle hair, skin pigmentation, and oedema from hypoalbuminemia. Leishmania tropica causes oriental sore (cutaneous leishmaniasis): solitary or multiple ulcerating papules healing with scarring. Leishmania braziliensis causes espundia (mucocutaneous leishmaniasis), a destructive disease of mucosal tissue.
Laboratory Principle
Definitive aetiological diagnosis requires demonstrating the amastigote (LD body) form in stained smears of splenic aspirate, bone marrow, or peripheral blood, or by culturing the promastigote form on specialised media (NNN, BHI agar, Schneider's medium). Serology (ELISA, CIEP, DOT-ELISA) and antigen/PCR-based tests supplement microscopy, particularly in immunocompromised patients where sensitivity of direct methods may be reduced.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Leishman Stain | Standard | Staining smears to visualise amastigote/promastigote forms | Room temperature, protect from light |
| NNN Medium (Novy-MacNeal-Nicolle) | Biphasic | Culture medium for promastigote isolation | 2–8°C before use |
| ELISA Kit (Leishmania antibody/antigen) | Manufacturer specified | Serological detection of leishmaniasis | 2–8°C |
Step-by-Step Procedure
Collect splenic aspirate, bone marrow, or peripheral blood/buffy coat as appropriate.
Prepare thin smears and stain with Leishman or Giemsa stain.
Examine under oil immersion for amastigote (LD) bodies within macrophages.
Inoculate specimen onto NNN or Schneider's medium and incubate at 22–26°C for promastigote growth.
Perform ELISA, CIEP or antigen detection tests to support or confirm diagnosis, especially if microscopy is negative.
Flow Diagram
Quality Control
Reference-stained slides with known LD bodies are examined periodically to maintain staff proficiency in recognising amastigote forms, and culture media are checked for sterility and growth support before use.
Participation in parasitology/serology External Quality Assessment schemes verifies inter-laboratory consistency in LD body recognition and serological test performance.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Amastigote (LD) bodies seen in splenic aspirate | Confirms visceral leishmaniasis (kala azar) | Initiate antileishmanial therapy; monitor hepatosplenomegaly |
| Ulcerating skin papule with promastigotes on culture | Suggests cutaneous leishmaniasis (oriental sore) | Confirm species; treat to prevent scarring |
| Destructive mucosal lesion | Suggests mucocutaneous leishmaniasis (espundia) | Refer for specialist management; assess for L. braziliensis |
Common Errors & How to Avoid Them
Cause: Amastigotes may be sparse and easily overlooked, especially in early or treated disease.
Prevention: Examine multiple fields carefully under oil immersion; consider culture or serology if smear is negative.
Cause: Delay reduces organism viability and culture yield.
Prevention: Inoculate NNN or Schneider's medium promptly after specimen collection.
Cause: Up to 40–60% of HIV/AIDS patients may be seronegative despite active infection.
Prevention: Do not rely on serology alone in immunocompromised patients; use microscopy/culture/PCR as well.
Laboratory Tips from the Bench
When examining a splenic aspirate smear, focus on macrophages first — amastigotes cluster intracellularly and are easy to miss if you scan only free organisms.
Remember the kinetoplast stains bright red on Leishman/Giemsa stain, giving the classic 'dot-dash' appearance of nucleus plus kinetoplast within the amastigote.
Memory tip: 'Donovani = Deep organs (Kala azar), Tropica = Top layer of skin (Oriental sore), Braziliensis = Bad mucosal destruction (Espundia)'.
Important Notes
In HIV/AIDS patients, up to 40–60% of leishmaniasis cases may be seronegative, so a negative antibody test does not exclude infection in immunocompromised individuals — direct demonstration or PCR should be pursued.
Since transmission depends on the sand fly vector, effective public health control of leishmaniasis requires vector control measures in addition to individual case management.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgePresents with 4 months of intermittent low-grade fever, progressive abdominal distension, pallor, weight loss and generalised weakness.
Intermittent fever, massive hepatosplenomegaly, anaemia, reversed A:G ratio and amastigote bodies on splenic aspirate together confirm a diagnosis of visceral leishmaniasis (kala azar).
- →Kala azar classically presents with prolonged fever, hepatosplenomegaly, anaemia and wasting
- →Splenic aspirate demonstrating amastigote (LD) bodies is diagnostic
- →Reversed albumin:globulin ratio is a supportive non-specific laboratory clue
Frequently Asked Questions
Leishmania is transmitted by the bite of an infected female sand fly of the genus Phlebotomus or Lutzomiya, and rarely through infected blood transfusion.
In immunocompromised individuals, particularly those with HIV/AIDS, 40–60% of cases may be seronegative despite active infection, so direct microscopy, culture, or PCR should be used alongside or instead of serology.
Kala azar (Leishmania donovani) is a visceral disease affecting the reticuloendothelial system; oriental sore (Leishmania tropica) is a localised cutaneous ulcer; espundia (Leishmania braziliensis) is a destructive mucocutaneous disease affecting the nose, mouth and throat.
Quick Revision
10-Minute ReviewKey Takeaways
- Leishmaniasis presents in three distinct clinical forms depending on the infecting species.
- Amastigote and promastigote forms are morphologically distinct and occur in different hosts.
- Splenic aspirate/bone marrow smear demonstrating LD bodies is the gold standard diagnostic method.
- Serology and culture provide supportive or alternative diagnostic routes.
- Sand fly vector control is essential for public health management of leishmaniasis.
- Immunocompromised patients require caution when interpreting negative serology.
Competency Checklist
Track Your MasteryReferences
- Ananthanarayan R, Paniker CKJ. Textbook of Microbiology. 10th ed. Universities Press.
- Chatterjee KD. Parasitology (Protozoology and Helminthology). 13th ed. CBS Publishers.
- Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 13th ed. Mosby.